<i>C. elegans</i> (VIDEO)

University of Texas at Austin

Caption

Texas Engineers have developed the first large-scale in vivo drug discovery platform using C. elegans -- a transparent roundworm that is used in the study of neurodegenerative diseases, including Parkinson's, Huntington's and Alzheimer's.

Credit

Cockrell School of Engineering

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.